|
Press Releases |
|
 |
|
Friday, April 25, 2025 |
|
Edvantage Group Announces FY2025 Interim Results |
Edvantage Group Holdings Limited ('Edvantage Group' or the 'Group', stock code: 0382.HK) has announced its unaudited FY2025 Interim Results for the six months ended 28 February 2025 (the 'Reporting Period'). more info >> |
|
中滙集團公佈2025財年中期業績 |
中滙集團控股有限公司 (「中滙集團」或「集團」,股份代號:0382.HK)公佈截至2025年2月28日止六個月(「報告期」)之未經審核之2025財年中期業績。 more info >> |
|
Friday, November 29, 2024 |
|
Edvantage Group Announces FY2024 Annual Results |
Edvantage Group Holdings Limited ("Edvantage Group" or the "Group", stock code: 0382.HK) has announced its audited FY2024 Annual Results for the year ended 31 August 2024 (the "Reporting Period"). During the Reporting Period, the Group actively responded to national policies, vigorously promoted industry-education integration, deepened the connotations of international education, continued to introduce unique new featured majors that match market and industry demands and fully embraced artificial intelligence ("AI", succeeding in raising education quality and brand presence, thereby achieving steady growth in performance year after year. more info >> |
|
中滙集團公佈2024財年全年業績 |
中滙集團控股有限公司 (「中滙集團」或「集團」,股份代號:0382.HK)公布截至2024年8月31日止年度(「報告期」)之經審核2024財年全年業績。 more info >> |
|
Friday, April 26, 2024 |
|
中滙集團公佈2024財年中期業績 |
中滙集團控股有限公司(「中滙集團」或「集團」,股份代號:0382.HK)公佈截至2024年2月29日止六個月(「報告期」)之未經審核之2024財年中期業績。報告期內,在積極回應國家政策、緊貼市場需求和產業發展趨勢的背景下,集團持續加大辦學投入,深化產教融合和校企合作,不斷優化職業教育學科專業佈局,以實現學校與企業間就業無縫銜接的可持續發展,業績穩健提升。 more info >> |
|
Edvantage Group Announces FY2024 Interim Results |
Edvantage Group Holdings Limited ("Edvantage Group" or the "Group", stock code: 0382.HK) has announced its unaudited FY2024 Interim Results for the six months ended 29 February 2024 (the "Reporting Period"). more info >> |
|
Friday, November 24, 2023 |
|
中滙集團公布2023財年全年業績 |
中滙集團控股有限公司 (「中滙集團」或「集團」,股份代號:0382.HK)公佈截至2023年8月31日止年度(「報告期」)之經審核2023財年全年業績。 more info >> |
|
Edvantage Group Announces FY2023 Annual Results |
Edvantage Group Holdings Limited ("Edvantage Group" or the "Group", stock code: 0382.HK), has announced its audited FY2023 Annual Results for the year ended 31 August 2023 (the "Reporting Period"). more info >> |
|
Wednesday, July 26, 2023 |
|
中滙集團公佈2023財年首三季度業務進展 |
粵港澳大灣區最大的民辦商科高等及職業教育集團中滙集團控股有限公司(「中滙集團」或「集團」,股份代號:0382.HK)公佈截至2023年5月31日止九個月(「回顧期」)之未經審核之財務與營運最新資料。 more info >> |
|
Edvantage Group Announces its Business Update for First Three Quarters of FY2023 |
Edvantage Group Holdings Limited ("Edvantage Group" or the "Group", stock code: 0382.HK), the largest private business higher and vocational education group in the Greater Bay Area, has announced its unaudited financial data and business update for the nine months ended 31 May 2023 (the "Period under Review"). more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Team Mitsubishi Ralliart Triumphs at Asia Cross Country Rally 2025 with Chayapon Yotha's Overall Victory and Team Award
Aug 18, 2025 15:22 JST
|
|
|
UNFPA and NEC Collaborate to Build Beneficiary Information Management and e-Voucher System
Aug 18, 2025 14:38 JST
|
|
|
Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games
Aug 18, 2025 10:35 HKT/SGT
|
|
|
The Business Show Asia 2025 Set to Inspire, Connect, and Transform Businesses
Aug 18, 2025 10:30 HKT/SGT
|
|
|
勇奪12金14銀11銅 首程控股多家被投企業閃耀世界人形機器人運動會
Aug 18, 2025 10:23 HKT/SGT
|
|
|
Anime Tokyo Station Surpasses 200,000 Visitors
Aug 18, 2025 11:00 JST
|
|
|
斩获12金14银11铜 摘得大满贯!首程控股多家被投企业闪耀世界人形机器人运动会
Aug 18, 2025 09:57 HKT/SGT
|
|
|
Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China
Aug 18, 2025 9:11 JST
|
|
|
RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements
Aug 16, 2025 15:27 HKT/SGT
|
|
|
WL Delicious Announced 2025 Interim Results
Aug 16, 2025 15:25 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 16, 2025 14:55 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 16, 2025 14:55 HKT/SGT
|
|
|
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 16, 2025 14:54 HKT/SGT
|
|
|
How Do AI Workflow Automations Work?
Aug 16, 2025 00:00 HKT/SGT
|
|
|
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Aug 15, 2025 23:18 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|